Svar Life Science

December 19, 2024

INTERVIEW: Advancing Complement Research—Insights from Two Complement Excellence Award Recipients

As the year draws to a close, we want to shine a spotlight on the remarkable achievements of Dr. Elena Goicoechea de Jorge and Dr. Sophie Chauvet, who were honored earlier this year with the prestigious Svar Complement Excellence Award at the European Meeting on Complement in Human Diseases (EMCHD) in Lübeck, Germany.

Their groundbreaking contributions to complement research have inspired the scientific community and advanced our understanding of complement-mediated diseases. As we look back on this milestone and their impactful work, we also look ahead to the exciting potential and opportunities for complement research in the coming year.

Uncover the fascinating connection between complement and cancer and explore the potential for prognostic biomarkers in these interviews. Download yours by filling out the form.

December 19, 2024

INTERVIEW: Advancing Complement Research—Insights from Two Complement Excellence Award Recipients

As the year draws to a close, we want to shine a spotlight on the remarkable achievements of Dr. Elena Goicoechea de Jorge and Dr. Sophie Chauvet, who were honored earlier this year with the prestigious Svar Complement Excellence Award at the European Meeting on Complement in Human Diseases (EMCHD) in Lübeck, Germany.

Their groundbreaking contributions to complement research have inspired the scientific community and advanced our understanding of complement-mediated diseases. As we look back on this milestone and their impactful work, we also look ahead to the exciting potential and opportunities for complement research in the coming year.

Uncover the fascinating connection between complement and cancer and explore the potential for prognostic biomarkers in these interviews. Download yours by filling out the form.

Dr. Chauvet: 

- Translating Research into Care

Dr. Chauvet’s research focuses on complement-mediated kidney diseases like C3G and aHUS, where she has identified biomarkers such as C3 and sC5b-9 to predict patient outcomes. Her discovery of autoantibodies targeting factor B provides critical tools for diagnosing acute postinfectious glomerulonephritis. With her team, she is pushing boundaries by exploring innovative treatments like bispecific antibodies to regulate complement activity.
Read the full interview

Dr. Goicoechea de Jorge: 

- Targeting Dysregulation

A leader in complement-mediated diseases like aHUS and C3G, Dr. Goicoechea de Jorge’s research highlights the role of factor H (FH) and FH-related proteins (FHRs) in alternative pathway overactivation. Her identification of FHR1 as a therapeutic target offers hope for precision therapies that modulate, rather than inhibit, complement activity. She is also pioneering the use of AI to analyze genetic data, advancing personalized medicine.
Read the full interview

Looking Back and Ahead

As we celebrate the accomplishments of these extraordinary researchers, their work reminds us how far complement research has come - and how much potential lies ahead. From our prestigious award ceremony to the ongoing improvements being made in labs all over the world, we look forward to 2025, when we will continue our journey of innovation, uncover new insights, and lead the way in research. To support your journey in exploring the latest in complement science, don’t forget to visit our Resource Center. Whether you're seeking technical documentation, insightful videos, or scientific publications, it’s your one-stop hub for staying informed and inspired.

To support your journey in exploring the latest in complement science, don’t forget to visit our Resource Center. Whether you're seeking technical documentation, insightful videos, or scientific publications, it’s your one-stop hub for staying informed and inspired.